Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

White House Continues To Push For Higher User Fees From Industry

Executive Summary

The White House expressed general support for the US House-passed user fee reauthorization bill while also demanding user fees be increased, creating some confusion in industry.

Advertisement

Related Content

Senate Approves FDA User Fee Reauthorization Bill On 94-1 Vote
Capitol Hill Update: Congress Gets Reprieve On User Fee Passage, While AdvaMed Weighs Device Tax Options
Lacking A New Budget Cap, Senate Panel Passes $2.8Bn Funding Bill For FDA
US FDA User-Fee Bill Swiftly Passes US House, Now Moves To Senate
Senators To Trump Administration: 'Way Too Late' To Change US FDA Budget Structure Now
Trump Budget: FDA-Regulated Firms Should Pay 'Their Share' In User Fees

Topics

Advertisement
UsernamePublicRestriction

Register

MT105163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel